Cutaneous T-Cell Lymphoma (CTCL) Overview
Learn About Cutaneous T-Cell Lymphoma (CTCL)
- Cutaneous T-cell lymphoma
- CTCL
City Of Hope Medical Foundation
Christiane Querfeld is a Dermatologist in Newport Beach, California. Dr. Querfeld is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). Her top areas of expertise are Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.
City Of Hope Medical Foundation
Steven Rosen is a Hematologist Oncology specialist and a Hematologist in South Pasadena, California. Dr. Rosen is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). His top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Yale University
Michael Girardi is a Dermatologist in New Haven, Connecticut. Dr. Girardi is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). His top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.
Summary: The purpose of this study is to understand and determine if ruxolitinib added to pembrolizumab is safe and effective for the treatment of relapsed or refractory Hodgkin and non-Hodgkin lymphomas.
Summary: To study the safety and effectiveness of tofacitinib 2% cream in treating early-stage CTCL.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

